Does Metformin Lower hsCRP? Unpacking the Anti-Inflammatory Effects
•
4 min read
A 2022 systematic review and meta-analysis found a statistically significant reduction in both C-reactive protein (CRP) and high-sensitivity C-reactive protein (hsCRP) when comparing metformin treatment to placebo in type 2 diabetes patients. However, research on whether **metformin lower hsCRP** has shown conflicting results, suggesting a complex relationship influenced by various factors, including treatment duration and patient population.
